Search

There is still limited information about how, and to what extent, patients with Persistent Postural-Perceptual Dizziness (PPPD) feel inadequate in their daily lives. This study aims to evaluate the physical, functional, and emotional disability related to dizziness in patients diagnosed with PPPD, and to investigate the frequency of anxiety disorder, depression, and migraine. The files of patients who were diagnosed PPPD in the neurology outpatient clinic at our hospital were retrospectively reviewed. The results of the Dizziness Handicap Inventory (DHI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI), which were implemented for treatment planning, were evaluated. Headache complaints were examined for whether they were compatible with migraine. Of the 65 patients diagnosed with Persistent postural-perceptual dizziness, 89% were female, 11% were male, and the mean age was 39. The total mean score of the DHI was 55.3. 86.1% of the patients experienced moderate or severe dizziness handicap. Moderate or severe depression was identified in 50.8% of the patients, moderate or severe anxiety in 80.8%, and migraine comorbidity in 70.8% of the patients. The majority of the patients with PPPD were in the young-middle age group and female. It was concluded that dizziness, migraine, depression, and anxiety disorder highly adversely affected the health-related quality of life of the patients. [ABSTRACT FROM AUTHOR]

Psychiatric findings may be seen in Fibromyalgia (FM) patients. We aimed to evaluate the relationship between anxiety, depression, and pain catastrophizing in FM patients and normal individuals. The study group consisted of FM patients and a healthy control group. Socio-demographic data form, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Visual Analogue Scale (VAS), Fibromyalgia Impact Questionnaire (FIQ), and Pain Catastrophizing Scale (PCS) were administered to the participants. It was evaluated whether there was a statistical difference between the groups in terms of BDI, BAI, PCS, VAS, and FIQ. Of the 178 patients in our study, 85 were FM patients and 93 were control groups. The BDI, BAI, PCS, PCSH (PCS Helplessness), PCSM (PCS Magnification), and PCSR (PCS Rumination) were found to be higher in FM patients compared to the control group. The FM patients were found to have moderate depression according to the BDI score (18.7±10.6) and moderate anxiety according to the BAI score (16.5±9.9). There was a positive correlation between BDI and BAI, FIQ and VAS, PCS and BDI, BAI and FIQ, and BAI and FIQ. It was found that the FM patients had "moderate" depression and anxiety, and their level of pain catastrophizing increased with the increase in depression and anxiety severity. [ABSTRACT FROM AUTHOR]

We aimed to evaluate the psychosexual impact of being diagnosed with human papillomavirus (HPV). A cross-sectional study was conducted to assess the anxiety and depression levels and sexual functions in women with and without HPV between March and May 2021. Beck anxiety inventory, the Beck depression inventory, and the Libido scoring system scales were used as scales. A total of 575 respondents were included; 292 (50.2%) were HPV-negative, and 283 (49.8%) were HPV-positive, of whom 170 (60,1%) had high-risk HPV genotypes 16/18 and 113 (39.9%) had non-16/18 high-risk HPV-positive patients. There was no significant association between HPV-negative and HPV-positive patients in terms of sociodemographic characteristics. While 21.6% of the HPV-positive group experienced masturbation, it was 15.1% in the HPV-negative group (p=0.044). While severe depression was 4.9% in HPV-positive women, this rate was 1.4% in HPV-negative women (p=0.002). The present study showed that being diagnosed with HPV made a significant difference in sexual function, except for sexual interest, but increased anxiety and depression scores. Sexual dysfunction following an HPV diagnosis cannot be explained solely by depression and anxiety. [ABSTRACT FROM AUTHOR]

The aim of this study was to compare the anxiety, depression, and quality of life of husbands of women with breast cancer referred to the chemotherapy clinic with husbands of non-affected wives. This was a case-control study, with purposive-convenience sampling method. 190 husbands of patients with or without breast cancer participate in this study. Data collection tools included a four-part questionnaire, consisted of demographic characteristics, shortened form of quality of life questionnaire, Beck depression inventory, and Beck anxiety inventory. In the areas of social relations and living environment (QolD3, QolD4), a statistically significant difference was found between the two groups in quality of life (p-value < 0.001). Pearson correlation coefficient showed a statistically significant difference in the case group between the history of chemotherapy and mean anxiety score (p-value < 0.001), and quality of life with number of children (p-value < 0.002). The findings of this study showed that in addition to giving attention to the patients, attention to health needs and quality of life of their spouses is also a priority. [ABSTRACT FROM AUTHOR]

We aimed to investigate the impact of Human Papillomavirus (HPV) positivity on women's mental health and sexual dysfunction (SD). Anxiety, hopelessness, and depression were investigated in this study as common psychological problems. This prospective cross-sectional case-control study was done on 213 participants who attended gynecology clinic from February 2021 to May 2022. The Turkish version of Female Sexual Function Index (FSFI)-6 was used to measure SD in women. The Turkish version of Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Beck Hopelessness Scale (BHS) was used to measure depression, anxiety and hopelessness in women. According to the HPV test results, the subjects were divided into two groups: 1st group as HPV positive and 2nd group as HPV negative. 97 women in the 1st group and 116 patients in the 2nd group were included in the study. The participants' age and body mass index (BMI) were 33.91±3.74 and 24.88±3.01, respectively. There was a significant difference between HPV-positive and HPV-negative women in FSFI total scores and all subdomains (p-value<0.05). There was a significant difference in BDI, BHS, and BAI (p-value<0.05). There was a significant correlation between the FSFI and BAI in HPV-positive group. There was a significant correlation between the FSFI and BAI in HPV-negative group. There was a significant correlation between the FSFI and BDI in HPV-negative group. The health system should support women with HPV in terms of mental health. These women are more exposed to depression, anxiety, hopelessness, and SD. [ABSTRACT FROM AUTHOR]